Why do you conduct in vivo validation studies for your cancer artificial intelligence predictions using the CertisAI platform?

Unlike other cancer artificial intelligence platforms, CertisAI predictions are validated in in vivo models — clinically relevant, well characterized, low passage patient-derived xenografts (PDX) from the BarneyOI Cancer Model Database.